Quotient Biodiagnostics Raises $11.2 Million of Growth Finance Led by Galen Partners

Newtown, PA and Edinburgh, Scotland, March 5, 2012 /PR Newswire/ -- Quotient Biodiagnostics Holdings Limited (“Quotient”), a global transfusion diagnostics Group, is pleased to announce that it has completed an $11.2 million growth equity financing led by Galen Partners, a US-based healthcare venture capital investment firm.

Get Answers Here